Information de reference pour ce titreAccession Number: | 00007783-201802000-00013.
|
Author: | Bloch, Konrad E 1,2; Huber, Fabienne 1; Furian, Michael 1; Latshang, Tsogyal D 1; Lo Cascio, Christian M 1; Nussbaumer-Ochsner, Yvonne 1; Senn, Oliver 3; Russi, Erich W 1, 2; Kohler, Malcolm 1, 2; Schoch, Otto D 4; Turk, Alexander 5; Imhof, Edelbert 6; Laube, Irene 6; Matthews, Felix 1; Thurnheer, Robert 7
|
Institution: | (1)Sleep Disorders Center and Pulmonary Division, University Hospital Zurich, Zurich, Switzerland, (2)Zurich Center for Interdisciplinary Sleep Research, University of Zurich, Zurich, Switzerland, (3)Institute of Primary Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland, (4)Sleep Disorders Center and Pulmonary Division, Cantonal Hospital St. Gallen, St. Gallen, Switzerland, (5)Sleep Disorders Center and Pulmonary Division, Zurich Rehabilitation Clinic, Wald, Switzerland, (6)Sleep Disorders Center and Pulmonary Division, City Hospital Triemli, Zurich, Switzerland, (7)Sleep Disorders Center and Pulmonary Division, Cantonal Hospital Munsterlingen, Munsterlingen, Switzerland,
|
Title: | Autoadjusted versus fixed CPAP for obstructive sleep apnoea: a multicentre, randomised equivalence trial.[Article]
|
Source: | Thorax. 73(2):174-184, February 2018.
|
Abstract: | Background: The obstructive sleep apnoea syndrome (OSAS) is conventionally treated by continuous positive airway pressure set at a fixed level (fCPAP). Automatic mask pressure adjustment (autoCPAP) is increasingly used during home therapy. We investigated whether autoCPAP is equivalent to fCPAP in improving sleepiness in patients with OSAS in the long-term.
Methods: In this multicentre equivalence trial, 208 patients with OSAS, with median Epworth sleepiness score (ESS) 13, apnoea/hypopnoea index 48.4/hour, were randomised to treatment with autoCPAP (5-15 mbar) or fCPAP (pressure set at the 90th percentile applied by autoCPAP during 2-4 weeks adaptation). Coprimary outcomes were changes in subjective and objective sleepiness from baseline to 2 years after treatment. Equivalence ranges were +/-2 points in ESS and +/-3 min sleep resistance time evaluated by recording responses to light signals.
Results: At 2 years, in the intention to treat analysis, the reduction in sleepiness versus pretreatment baseline was similar in patients using autoCPAP (n=113, mean ESS-change -6.3, 95% CI -7.1 to -5.5; sleep resistance time +8.3 min, +6.9 to +9.7) and fCPAP (n=95, mean ESS-change -6.2, 95% CI -7.0 to -5.3; sleep resistance time +6.3 min, +4.7 to +7.8). The 95% CI of difference in ESS-reduction between autoCPAP and fCPAP was -0.9 to +1.4 and the 95% CI of difference in increase in sleep resistance time was -2.6 to +1.0 min. Blood pressure reduction and OSAS-related costs were similar between groups.
Conclusions: AutoCPAP and fCPAP are equivalent within prespecified ranges in improving subjective and objective sleepiness in patients with OSAS over the course of 2 years. Costs of these treatments are similar.
Trial registration number: ClinicalTrials.gov NCT00280800.
(C) 2018 BMJ Publishing Group Ltd & British Thoracic Society
|
Author Keywords: | sleep apnoea; non invasive ventilation.
|
References: | 1. Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet 2014;383:736--47. doi:10.1016/S0140-6736(13)60734-5.
2. Marin JM, Agusti A, Villar I, et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA 2012;307:2169--76. doi:10.1001/jama.2012.3418.
3. Heinzer R, Vat S, Marques-Vidal P, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med 2015;3:310--8. doi:10.1016/S2213-2600(15)00043-0.
4. Epstein LJ, Kristo D, Strollo PJ, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 2009;5:263--76.
5. Morgenthaler TI, Aurora RN, Brown T, et al. Practice parameters for the use of autotitrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome: an update for 2007. An American Academy of Sleep Medicine report. Sleep 2008;31:141--7. doi:10.1093/sleep/31.1.141.
6. Masa JF, Jimenez A, Duran J, et al. Alternative methods of titrating continuous positive airway pressure: a large multicenter study. Am J Respir Crit Care Med 2004;170:1218--24. doi:10.1164/rccm.200312-1787OC.
7. Smith I, Lasserson TJ. Pressure modification for improving usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea. Cochrane Database Syst Rev 2009;: CD003531. doi:10.1002/14651858.CD003531.pub3.
8. Ip S, D'Ambrosio C, Patel K, et al. Auto-titrating versus fixed continuous positive airway pressure for the treatment of obstructive sleep apnea: a systematic review with meta-analyses. Syst Rev 2012;1:20. doi:10.1186/2046-4053-1-20.
9. Xu T, Li T, Wei D, et al. Effect of automatic versus fixed continuous positive airway pressure for the treatment of obstructive sleep apnea: an up-to-date meta-analysis. Sleep Breath 2012;16:1017--26. doi:10.1007/s11325-011-0626-6.
10. Bloch KE, Schoch OD, Zhang JN, et al. German version of the Epworth Sleepiness Scale. Respiration 1999;66:440--7. doi:10.1159/000029408.
11. Chesson AL, Berry RB, Pack A; American Academy of Sleep Medicine., American Thoracic Society., American College of Chest Physicians. Practice parameters for the use of portable monitoring devices in the investigation of suspected obstructive sleep apnea in adults. Sleep 2003;26:907--13. doi:10.1093/sleep/26.7.907.
12. Ware JE, Snow KK, Kosinski M, et al. SF-36 health survey: manual and interpretation guide. Boston: The Health Institute, New England Medical Center, 1993;.
13. Weaver TE, Laizner AM, Evans LK, et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep 1997;20:835--43.
14. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21:271--92. doi:10.1016/S0167-6296(01)00130-8.
15. Bennett LS, Stradling JR, Davies RJ. A behavioural test to assess daytime sleepiness in obstructive sleep apnoea. J Sleep Res 1997;6:142--5. doi:10.1046/j.1365-2869.1997.00039.x.
16. Parati G, Lombardi C, Hedner J, et al. Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens 2012;30:633--46. doi:10.1097/HJH.0b013e328350e53b.
17. Robinson GV, Pepperell JC, Segal HC, et al. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 2004;59:777--82. doi:10.1136/thx.2003.018739.
18. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003;107:1129--34. doi:10.1161/01.CIR.0000052627.99976.18.
19. Senn O, Brack T, Matthews F, et al. Randomized short-term trial of two autoCPAP devices versus fixed continuous positive airway pressure for the treatment of sleep apnea. Am J Respir Crit Care Med 2003;168:1506--11. doi:10.1164/rccm.200304-542OC.
20. Nussbaumer Y, Bloch KE, Genser T, et al. Equivalence of autoadjusted and constant continuous positive airway pressure in home treatment of sleep apnea. Chest 2006;129:638--43. doi:10.1378/chest.129.3.638.
21. Julious SA. Sample sizes for clinical trials with normal data. Stat Med 2004;23:1921--86. doi:10.1002/sim.1783.
22. Piaggio G, Elbourne DR, Pocock SJ, et al. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA 2012;308:2594--604. doi:10.1001/jama.2012.87802.
23. White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med 2011;30:377--99. doi:10.1002/sim.4067.
24. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989;27:S178--89. doi:10.1097/00005650-198903001-00015.
25. Jones B, Jarvis P, Lewis JA, et al. Trials to assess equivalence: the importance of rigorous methods. BMJ 1996;313:36--9. doi:10.1136/bmj.313.7048.36.
26. McDaid C, Griffin S, Weatherly H, et al. Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis. Health Technol Assess 2009;13:iii-iv, xi-xiv, 1-119, 143-274. doi:10.3310/hta13040.
27. Bratton DJ, Gaisl T, Schlatzer C, et al. Comparison of the effects of continuous positive airway pressure and mandibular advancement devices on sleepiness in patients with obstructive sleep apnoea: a network meta-analysis. Lancet Respir Med 2015;3:869--78. doi:10.1016/S2213-2600(15)00416-6.
28. Vennelle M, White S, Riha RL, et al. Randomized controlled trial of variable-pressure versus fixed-pressure continuous positive airway pressure (CPAP) treatment for patients with obstructive sleep apnea/hypopnea syndrome (OSAHS). Sleep 2010;33:267--71. doi:10.1093/sleep/33.2.267.
29. West SD, Jones DR, Stradling JR. Comparison of three ways to determine and deliver pressure during nasal CPAP therapy for obstructive sleep apnoea. Thorax 2006;61:226--31. doi:10.1136/thx.2005.046300.
30. Pepin JL, Tamisier R, Baguet JP, et al. Fixed-pressure CPAP versus auto-adjusting CPAP: comparison of efficacy on blood pressure in obstructive sleep apnoea, a randomised clinical trial. Thorax 2016;71:726--33. doi:10.1136/thoraxjnl-2015-207700.
31. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338: b1665. doi:10.1136/bmj.b1665.
|
Language: | English.
|
Document Type: | Sleep: Original Article.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0040-6376
|
NLM Journal Code: | vqw, 0417353
|
DOI Number: | https://dx.doi.org/10.1136/thora...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|